However, based on these in vivo results, it remains unclear that the anti-cardiac fibrosis activity of TP is related to which cell type of heart (cardiocytes, fibroblasts, and monocytes/macrophages, etc.), and whether TP functions through NLRP3 inflammasome. This evidence concerns the gene NLRP3 and fibrosis.